Target intelligence / Profile preview

Calcium in bone matrix

Molecular classification
Other (inorganic mineral component), Not applicable (not a protein, enzyme, receptor, etc.)
01

Overview

Calcium in the bone matrix refers to inorganic calcium ions incorporated primarily as part of hydroxyapatite crystals \(\mathrm{Ca_{10}(PO_4)_6(OH)_2}\), which are deposited onto an organic collagen scaffold during ossification. This process gives bones their characteristic hardness and compressive strength while serving as the body's principal reservoir for systemic regulation of blood calcium levels. The dynamic balance between deposition (by osteoblasts) and resorption (by osteoclasts) maintains both structural integrity and metabolic needs. While critical for health—and central to diseases like osteoporosis—this entity is not itself considered a classical therapeutic target but rather part of broader physiological pathways involving multiple cell types and regulatory hormones[1][2][3].

Other names
Bone calciumMatrix calciumHydroxyapatite-bound calcium
02

Mechanism of action

These drugs act indirectly by altering cellular processes that control deposition or mobilization of calcium from the bone matrix—primarily through effects on osteoblasts and osteoclasts—not by binding "calcium in the bone matrix" itself.

03

Biological functions

Provides mechanical strength and rigidity to bonesActs as a reservoir for systemic calcium homeostasisEssential for proper muscle contraction and nerve impulse transmission via regulation of blood calcium levels
04

Disease associations

Osteoporosis (altered bone mineralization)Osteomalacia/rickets (defective mineralization)Hypercalcemia/hypocalcemia due to abnormal release or storage of calcium from/in bones
05

Safety considerations

Therapeutic manipulation of skeletal calcium can lead to disturbances such as hypercalcemia or hypocalcemiaexcessive suppression of resorption may cause atypical fractures or impaired remodelingvitamin D toxicity can also result from over-supplementation
06

Interacting drugs

Bisphosphonates (e.g., alendronate) inhibit osteoclast-mediated resorption

3 more in the full profile.

07

Biomarkers

Serum markers reflecting changes in overall skeletal metabolism may be used for monitoring therapy affecting skeletal calcium stores; examples include serum/urine calcium levels, alkaline phosphatase, osteocalcin[8]C-terminal telopeptide

Beyond the preview

Go deeper on Calcium in bone matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium in bone matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call